T. Rowe Price Associates’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $340K | Buy |
|
|||||
|
2025
Q2 | $478K | Buy |
|
|||||
|
2025
Q1 | $274K | Buy |
|
|||||
|
2024
Q4 | $211K | Sell |
|
|||||
|
2024
Q3 | $6.71M | Buy |
|
|||||
|
2024
Q2 | $134K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $111K | Buy |
|
|||||
|
2023
Q1 | $76K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $140K | Sell |
|
|||||
|
2022
Q2 | $705K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | $2M | Buy |
|